Varian ranked first in oncology IT vendors

16 July 2008

Varian Medical Systems (NYSE:VAR) was ranked the leading supplier in its class in an independent study released by KLAS, a research firm that specialises in monitoring and reporting on the performance of healthcare vendors.

Varian's ARIA software, an information system for managing medical and radiation oncology practices, received top scores in study categories including: ease of use, quality of releases and updates, and compatibility with third party products.

According to the June 2008 Oncology report, Varian Medical Systems is "considered by many providers to have the most developed and comprehensive oncology solution". The report further states that "many Varian customers feel that the ARIA suite is the most robust solution for medical and radiation oncology available on the market today."

KLAS interviewed eleven potential vendors, but only three had sufficient number of active installations to qualify, the other two being IMPAC, and IntrinsiQ.

Varian was the only vendor to score above the group average in all four of the report's major categories: product/technology indicators, service indicators, success indicators, and business indicators. Varian scored above competitors in 23 of the forty indicators that the study measured.

The KLAS study predicts that Varian will continue to be seen as one of the most complete medical and radiation oncology solutions for some time to come.

"We're gratified to receive top marks in an objective survey of our customers," said Dow Wilson, president of the company's Oncology Systems business. "It validates the work we're doing to offer treatment centers a versatile set of best-in-class clinical tools for fighting cancer."

To top